Hy-Vee acquires two stores
SIOUX FALLS, S.D. Midwestern supermarket chain Hy-Vee will acquire two stores in the upper Midwest, Hy-Vee said Tuesday.
Hy-Vee agreed to purchase two stores from Sunshine Foods, one in Sioux Falls, S.D., and one in Windom, Minn. Des Moines, Iowa-based Hy-Vee already operates five stores in Sioux Falls and one in Windom.
“Sioux Falls is a key market for Hy-Vee, and the addition of these two stores will enable us to expand our services to more customers in more areas of the city,” Hy-Vee VP western region Paula Correy said . “In Windom, we will be able to replace our outdated store with a newer, larger facility.”
Smiling Planet announced partnership with Healthy Child Healthy World
LOS ANGELES Smiling Planet a new line of earth-friendly lifestyle products for kids, has joined the Healthy Child Healthy World network.
The partnership represents a joint commitment to raising awareness about preventing children’s exposure to harmful chemicals, and also reinforces the high standards of safety, quality, and environmental consciousness that Smiling Planet sets for its children’s dinnerware. Smiling Planet’s plates and bowls are specifically designed to be a safe and practical alternative to dinnerware containing melamine, BPA and other harmful chemicals, Smiling Planet said.
“Today’s parents are inundated with conflicting information about product safety, often leaving them unsure about which products are best,” said Freddy Deane, who co-founded Smiling Planet with wife Olivia Haviland. “We’re proud to join Healthy Child Healthy World to empower parents to find the safest possible products for their children, and for the planet.”
Sagent’s generic Imitrex receives regulatory approval
SCHAUMBURG, Ill. The Food and Drug Administration has approved a generic injected drug made by Sagent Pharmaceuticals for treating migraine attacks, Sagent said Monday.
The FDA approved Sagent’s sumatriptan succinate injection in the 6 mg per 0.5 milliliter strength. The drug is used to treat acute migraine attacks and cluster headache episodes.
Sumatriptan is a generic version of GlaxoSmithKline’s Imitrex. Injectable sumatriptan had $22 million in sales in 2009, according to IMS Health.